Phosphoproteomic studies of alamandine signaling in CHO‐MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled

Alamandine is a heptapeptide from the renin‐angiotensin system (RAS) with similar structure/function to angiotensin‐(1‐7) [ang‐(1‐7)], but they act via different receptors. It remains elusive whether alamandine is an antiproliferative agent like ang‐(1‐7). The goal of this study was to evaluate the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proteomics (Weinheim) 2022-09, Vol.22 (17), p.e2100255-n/a
Hauptverfasser: da Silva, Filipe Alex, Rodrigues‐Ribeiro, Lucas, Melo‐Braga, Marcella Nunes, Passos‐Silva, Danielle Gomes, Sampaio, Walkyria Oliveira, Gorshkov, Vladimir, Kjeldsen, Frank, Verano‐Braga, Thiago, Santos, Robson Augusto Souza
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 17
container_start_page e2100255
container_title Proteomics (Weinheim)
container_volume 22
creator da Silva, Filipe Alex
Rodrigues‐Ribeiro, Lucas
Melo‐Braga, Marcella Nunes
Passos‐Silva, Danielle Gomes
Sampaio, Walkyria Oliveira
Gorshkov, Vladimir
Kjeldsen, Frank
Verano‐Braga, Thiago
Santos, Robson Augusto Souza
description Alamandine is a heptapeptide from the renin‐angiotensin system (RAS) with similar structure/function to angiotensin‐(1‐7) [ang‐(1‐7)], but they act via different receptors. It remains elusive whether alamandine is an antiproliferative agent like ang‐(1‐7). The goal of this study was to evaluate the potential antiproliferative activity of alamandine and the underlying cellular signaling. We evaluated alamandine effect in the tumoral cell lines Mia PaCa‐2 and A549, and in the nontumoral cell lines HaCaT, CHO and CHO transfected with the alamandine receptor MrgD (CHO‐MrgD). Alamandine was able to reduce the proliferation of the tumoral cell lines in a MrgD‐dependent fashion. We did not observe any effect in the nontumoral cell lines tested. We also performed proteomics and phosphoproteomics to study the alamandine signaling in Mia PaCa‐2 and CHO‐MrgD. Data suggest that alamandine induces a shift from anaerobic to aerobic metabolism in the tumoral cells, induces a negative regulation of PI3K/AKT/mTOR pathway and activates the transcriptional factor FoxO1; events that could explain, at least partially, the observed antiproliferative effect of alamandine. This study provides for the first time a comprehensive investigation of the alamandine signaling in tumoral (Mia PaCa‐2) and nontumoral (CHO‐MrgD) cells, highlighting the antiproliferative activity of alamandine/MrgD and its possible antitumoral effect.
doi_str_mv 10.1002/pmic.202100255
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2672706439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2709712683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4095-44ec51e5e735047b6fef54bc16812d2b622cd54c74f5c89e05b1ddf543f997e53</originalsourceid><addsrcrecordid>eNqFkTFv1DAUxy0EoqWwMiJLLCx32E6enbBVR6GVWrUDzJHjPN-5SuxgJ6269QMw8Bn7SerTlRu6VB5syz__3tP7E_KRsyVnTHwdB2eWgontBeAVOeSSw6KuJH-9P0NxQN6ldM0YV1Wt3pKDAiQIyfkh-Xu1CWnchDGGCUOW0TTNncNEg6W614P2nfNIk1t73Tu_ps7T1enlw_2_i7j-TvMz3cyZoqP2JqKessLoaJwPg6YG-z59o8c-g5PLRXpnMWboBilai2aiLtHZ36DrsXtP3ljdJ_zwtB-R3z9Ofq1OF-eXP89Wx-cLU7IaFmWJBjgCqgJYqVpp0ULZGi4rLjrRSiFMB6VRpQVT1cig5V2XkcLWtUIojsiXnTc39GfGNDWDS9tWtccwp0ZIJRSTZVFn9PMz9DrMMY8iU4rVigtZFZla7igTQ0oRbTNGN-h413DWbKNptjk1-5zyh09P2rkdsNvj_4PJAOyA2zyYuxd0zdXF2YoXkNcjmlahAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2709712683</pqid></control><display><type>article</type><title>Phosphoproteomic studies of alamandine signaling in CHO‐MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>da Silva, Filipe Alex ; Rodrigues‐Ribeiro, Lucas ; Melo‐Braga, Marcella Nunes ; Passos‐Silva, Danielle Gomes ; Sampaio, Walkyria Oliveira ; Gorshkov, Vladimir ; Kjeldsen, Frank ; Verano‐Braga, Thiago ; Santos, Robson Augusto Souza</creator><creatorcontrib>da Silva, Filipe Alex ; Rodrigues‐Ribeiro, Lucas ; Melo‐Braga, Marcella Nunes ; Passos‐Silva, Danielle Gomes ; Sampaio, Walkyria Oliveira ; Gorshkov, Vladimir ; Kjeldsen, Frank ; Verano‐Braga, Thiago ; Santos, Robson Augusto Souza</creatorcontrib><description>Alamandine is a heptapeptide from the renin‐angiotensin system (RAS) with similar structure/function to angiotensin‐(1‐7) [ang‐(1‐7)], but they act via different receptors. It remains elusive whether alamandine is an antiproliferative agent like ang‐(1‐7). The goal of this study was to evaluate the potential antiproliferative activity of alamandine and the underlying cellular signaling. We evaluated alamandine effect in the tumoral cell lines Mia PaCa‐2 and A549, and in the nontumoral cell lines HaCaT, CHO and CHO transfected with the alamandine receptor MrgD (CHO‐MrgD). Alamandine was able to reduce the proliferation of the tumoral cell lines in a MrgD‐dependent fashion. We did not observe any effect in the nontumoral cell lines tested. We also performed proteomics and phosphoproteomics to study the alamandine signaling in Mia PaCa‐2 and CHO‐MrgD. Data suggest that alamandine induces a shift from anaerobic to aerobic metabolism in the tumoral cells, induces a negative regulation of PI3K/AKT/mTOR pathway and activates the transcriptional factor FoxO1; events that could explain, at least partially, the observed antiproliferative effect of alamandine. This study provides for the first time a comprehensive investigation of the alamandine signaling in tumoral (Mia PaCa‐2) and nontumoral (CHO‐MrgD) cells, highlighting the antiproliferative activity of alamandine/MrgD and its possible antitumoral effect.</description><identifier>ISSN: 1615-9853</identifier><identifier>EISSN: 1615-9861</identifier><identifier>DOI: 10.1002/pmic.202100255</identifier><identifier>PMID: 35652611</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>1-Phosphatidylinositol 3-kinase ; AKT protein ; alamandine ; Angiotensin ; Anticancer properties ; Antiproliferatives ; cancer ; FOXO1 protein ; Humans ; Oligopeptides - metabolism ; Oligopeptides - pharmacology ; Pancreatic cancer ; Pancreatic carcinoma ; Pancreatic Neoplasms ; Phosphatidylinositol 3-Kinases ; phosphoproteomics ; Proteomics ; Receptors ; Receptors, G-Protein-Coupled - metabolism ; Renin ; renin‐angiotensin system ; Signaling ; Structure-function relationships ; TOR protein ; tumor</subject><ispartof>Proteomics (Weinheim), 2022-09, Vol.22 (17), p.e2100255-n/a</ispartof><rights>2022 Wiley‐VCH GmbH.</rights><rights>2022 Wiley-VCH GmbH.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4095-44ec51e5e735047b6fef54bc16812d2b622cd54c74f5c89e05b1ddf543f997e53</citedby><cites>FETCH-LOGICAL-c4095-44ec51e5e735047b6fef54bc16812d2b622cd54c74f5c89e05b1ddf543f997e53</cites><orcidid>0000-0002-7083-2588</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpmic.202100255$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpmic.202100255$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35652611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>da Silva, Filipe Alex</creatorcontrib><creatorcontrib>Rodrigues‐Ribeiro, Lucas</creatorcontrib><creatorcontrib>Melo‐Braga, Marcella Nunes</creatorcontrib><creatorcontrib>Passos‐Silva, Danielle Gomes</creatorcontrib><creatorcontrib>Sampaio, Walkyria Oliveira</creatorcontrib><creatorcontrib>Gorshkov, Vladimir</creatorcontrib><creatorcontrib>Kjeldsen, Frank</creatorcontrib><creatorcontrib>Verano‐Braga, Thiago</creatorcontrib><creatorcontrib>Santos, Robson Augusto Souza</creatorcontrib><title>Phosphoproteomic studies of alamandine signaling in CHO‐MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled</title><title>Proteomics (Weinheim)</title><addtitle>Proteomics</addtitle><description>Alamandine is a heptapeptide from the renin‐angiotensin system (RAS) with similar structure/function to angiotensin‐(1‐7) [ang‐(1‐7)], but they act via different receptors. It remains elusive whether alamandine is an antiproliferative agent like ang‐(1‐7). The goal of this study was to evaluate the potential antiproliferative activity of alamandine and the underlying cellular signaling. We evaluated alamandine effect in the tumoral cell lines Mia PaCa‐2 and A549, and in the nontumoral cell lines HaCaT, CHO and CHO transfected with the alamandine receptor MrgD (CHO‐MrgD). Alamandine was able to reduce the proliferation of the tumoral cell lines in a MrgD‐dependent fashion. We did not observe any effect in the nontumoral cell lines tested. We also performed proteomics and phosphoproteomics to study the alamandine signaling in Mia PaCa‐2 and CHO‐MrgD. Data suggest that alamandine induces a shift from anaerobic to aerobic metabolism in the tumoral cells, induces a negative regulation of PI3K/AKT/mTOR pathway and activates the transcriptional factor FoxO1; events that could explain, at least partially, the observed antiproliferative effect of alamandine. This study provides for the first time a comprehensive investigation of the alamandine signaling in tumoral (Mia PaCa‐2) and nontumoral (CHO‐MrgD) cells, highlighting the antiproliferative activity of alamandine/MrgD and its possible antitumoral effect.</description><subject>1-Phosphatidylinositol 3-kinase</subject><subject>AKT protein</subject><subject>alamandine</subject><subject>Angiotensin</subject><subject>Anticancer properties</subject><subject>Antiproliferatives</subject><subject>cancer</subject><subject>FOXO1 protein</subject><subject>Humans</subject><subject>Oligopeptides - metabolism</subject><subject>Oligopeptides - pharmacology</subject><subject>Pancreatic cancer</subject><subject>Pancreatic carcinoma</subject><subject>Pancreatic Neoplasms</subject><subject>Phosphatidylinositol 3-Kinases</subject><subject>phosphoproteomics</subject><subject>Proteomics</subject><subject>Receptors</subject><subject>Receptors, G-Protein-Coupled - metabolism</subject><subject>Renin</subject><subject>renin‐angiotensin system</subject><subject>Signaling</subject><subject>Structure-function relationships</subject><subject>TOR protein</subject><subject>tumor</subject><issn>1615-9853</issn><issn>1615-9861</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkTFv1DAUxy0EoqWwMiJLLCx32E6enbBVR6GVWrUDzJHjPN-5SuxgJ6269QMw8Bn7SerTlRu6VB5syz__3tP7E_KRsyVnTHwdB2eWgontBeAVOeSSw6KuJH-9P0NxQN6ldM0YV1Wt3pKDAiQIyfkh-Xu1CWnchDGGCUOW0TTNncNEg6W614P2nfNIk1t73Tu_ps7T1enlw_2_i7j-TvMz3cyZoqP2JqKessLoaJwPg6YG-z59o8c-g5PLRXpnMWboBilai2aiLtHZ36DrsXtP3ljdJ_zwtB-R3z9Ofq1OF-eXP89Wx-cLU7IaFmWJBjgCqgJYqVpp0ULZGi4rLjrRSiFMB6VRpQVT1cig5V2XkcLWtUIojsiXnTc39GfGNDWDS9tWtccwp0ZIJRSTZVFn9PMz9DrMMY8iU4rVigtZFZla7igTQ0oRbTNGN-h413DWbKNptjk1-5zyh09P2rkdsNvj_4PJAOyA2zyYuxd0zdXF2YoXkNcjmlahAA</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>da Silva, Filipe Alex</creator><creator>Rodrigues‐Ribeiro, Lucas</creator><creator>Melo‐Braga, Marcella Nunes</creator><creator>Passos‐Silva, Danielle Gomes</creator><creator>Sampaio, Walkyria Oliveira</creator><creator>Gorshkov, Vladimir</creator><creator>Kjeldsen, Frank</creator><creator>Verano‐Braga, Thiago</creator><creator>Santos, Robson Augusto Souza</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7083-2588</orcidid></search><sort><creationdate>202209</creationdate><title>Phosphoproteomic studies of alamandine signaling in CHO‐MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled</title><author>da Silva, Filipe Alex ; Rodrigues‐Ribeiro, Lucas ; Melo‐Braga, Marcella Nunes ; Passos‐Silva, Danielle Gomes ; Sampaio, Walkyria Oliveira ; Gorshkov, Vladimir ; Kjeldsen, Frank ; Verano‐Braga, Thiago ; Santos, Robson Augusto Souza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4095-44ec51e5e735047b6fef54bc16812d2b622cd54c74f5c89e05b1ddf543f997e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>1-Phosphatidylinositol 3-kinase</topic><topic>AKT protein</topic><topic>alamandine</topic><topic>Angiotensin</topic><topic>Anticancer properties</topic><topic>Antiproliferatives</topic><topic>cancer</topic><topic>FOXO1 protein</topic><topic>Humans</topic><topic>Oligopeptides - metabolism</topic><topic>Oligopeptides - pharmacology</topic><topic>Pancreatic cancer</topic><topic>Pancreatic carcinoma</topic><topic>Pancreatic Neoplasms</topic><topic>Phosphatidylinositol 3-Kinases</topic><topic>phosphoproteomics</topic><topic>Proteomics</topic><topic>Receptors</topic><topic>Receptors, G-Protein-Coupled - metabolism</topic><topic>Renin</topic><topic>renin‐angiotensin system</topic><topic>Signaling</topic><topic>Structure-function relationships</topic><topic>TOR protein</topic><topic>tumor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>da Silva, Filipe Alex</creatorcontrib><creatorcontrib>Rodrigues‐Ribeiro, Lucas</creatorcontrib><creatorcontrib>Melo‐Braga, Marcella Nunes</creatorcontrib><creatorcontrib>Passos‐Silva, Danielle Gomes</creatorcontrib><creatorcontrib>Sampaio, Walkyria Oliveira</creatorcontrib><creatorcontrib>Gorshkov, Vladimir</creatorcontrib><creatorcontrib>Kjeldsen, Frank</creatorcontrib><creatorcontrib>Verano‐Braga, Thiago</creatorcontrib><creatorcontrib>Santos, Robson Augusto Souza</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Proteomics (Weinheim)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>da Silva, Filipe Alex</au><au>Rodrigues‐Ribeiro, Lucas</au><au>Melo‐Braga, Marcella Nunes</au><au>Passos‐Silva, Danielle Gomes</au><au>Sampaio, Walkyria Oliveira</au><au>Gorshkov, Vladimir</au><au>Kjeldsen, Frank</au><au>Verano‐Braga, Thiago</au><au>Santos, Robson Augusto Souza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phosphoproteomic studies of alamandine signaling in CHO‐MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled</atitle><jtitle>Proteomics (Weinheim)</jtitle><addtitle>Proteomics</addtitle><date>2022-09</date><risdate>2022</risdate><volume>22</volume><issue>17</issue><spage>e2100255</spage><epage>n/a</epage><pages>e2100255-n/a</pages><issn>1615-9853</issn><eissn>1615-9861</eissn><abstract>Alamandine is a heptapeptide from the renin‐angiotensin system (RAS) with similar structure/function to angiotensin‐(1‐7) [ang‐(1‐7)], but they act via different receptors. It remains elusive whether alamandine is an antiproliferative agent like ang‐(1‐7). The goal of this study was to evaluate the potential antiproliferative activity of alamandine and the underlying cellular signaling. We evaluated alamandine effect in the tumoral cell lines Mia PaCa‐2 and A549, and in the nontumoral cell lines HaCaT, CHO and CHO transfected with the alamandine receptor MrgD (CHO‐MrgD). Alamandine was able to reduce the proliferation of the tumoral cell lines in a MrgD‐dependent fashion. We did not observe any effect in the nontumoral cell lines tested. We also performed proteomics and phosphoproteomics to study the alamandine signaling in Mia PaCa‐2 and CHO‐MrgD. Data suggest that alamandine induces a shift from anaerobic to aerobic metabolism in the tumoral cells, induces a negative regulation of PI3K/AKT/mTOR pathway and activates the transcriptional factor FoxO1; events that could explain, at least partially, the observed antiproliferative effect of alamandine. This study provides for the first time a comprehensive investigation of the alamandine signaling in tumoral (Mia PaCa‐2) and nontumoral (CHO‐MrgD) cells, highlighting the antiproliferative activity of alamandine/MrgD and its possible antitumoral effect.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35652611</pmid><doi>10.1002/pmic.202100255</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-7083-2588</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1615-9853
ispartof Proteomics (Weinheim), 2022-09, Vol.22 (17), p.e2100255-n/a
issn 1615-9853
1615-9861
language eng
recordid cdi_proquest_miscellaneous_2672706439
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects 1-Phosphatidylinositol 3-kinase
AKT protein
alamandine
Angiotensin
Anticancer properties
Antiproliferatives
cancer
FOXO1 protein
Humans
Oligopeptides - metabolism
Oligopeptides - pharmacology
Pancreatic cancer
Pancreatic carcinoma
Pancreatic Neoplasms
Phosphatidylinositol 3-Kinases
phosphoproteomics
Proteomics
Receptors
Receptors, G-Protein-Coupled - metabolism
Renin
renin‐angiotensin system
Signaling
Structure-function relationships
TOR protein
tumor
title Phosphoproteomic studies of alamandine signaling in CHO‐MrgD and human pancreatic carcinoma cells: An antiproliferative effect is unveiled
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A12%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phosphoproteomic%20studies%20of%20alamandine%20signaling%20in%20CHO%E2%80%90MrgD%20and%20human%20pancreatic%20carcinoma%20cells:%20An%20antiproliferative%20effect%20is%20unveiled&rft.jtitle=Proteomics%20(Weinheim)&rft.au=da%20Silva,%20Filipe%20Alex&rft.date=2022-09&rft.volume=22&rft.issue=17&rft.spage=e2100255&rft.epage=n/a&rft.pages=e2100255-n/a&rft.issn=1615-9853&rft.eissn=1615-9861&rft_id=info:doi/10.1002/pmic.202100255&rft_dat=%3Cproquest_cross%3E2709712683%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2709712683&rft_id=info:pmid/35652611&rfr_iscdi=true